Ta‐Chung Chao
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Pathology and Forensic Medicine top 5%
- Cancer Research top 10%
- Co-authors
- Ling‐Ming TsengLiu HChueh‐Chuan YenChun‐Yu LiuPo‐Min ChenTzeon-Jye ChiouWei-Shu WangMuh‐Hwa Yang
- Topics
- Cancer Treatment and Pharmacology (16 papers)HER2/EGFR in Cancer Research (15 papers)Advanced Breast Cancer Therapies (10 papers)
- Partner nations
- TaiwanUnited StatesSingapore
In The Last Decade
Ta‐Chung Chao
95 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 105
- Oncology 724
- Pulmonary and Respiratory Medicine 485
- Molecular Biology 317
- Pathology and Forensic Medicine 266
- Cancer Research 248
Countries citing papers authored by Ta‐Chung Chao
This map shows the geographic impact of Ta‐Chung Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ta‐Chung Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ta‐Chung Chao more than expected).
Fields of papers citing papers by Ta‐Chung Chao
This network shows the impact of papers produced by Ta‐Chung Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ta‐Chung Chao. The network helps show where Ta‐Chung Chao may publish in the future.
Co-authorship network of co-authors of Ta‐Chung Chao
This figure shows the co-authorship network connecting the top 25 collaborators of Ta‐Chung Chao. A scholar is included among the top collaborators of Ta‐Chung Chao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ta‐Chung Chao. Ta‐Chung Chao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 7 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 8 | |
| 6 | 13 | |
| 7 | 12 | |
| 8 | 10 | |
| 9 | 2 | |
| 10 | 11 | |
| 11 | 71 | |
| 12 | 54 | |
| 13 | 11 | |
| 14 | 24 | |
| 15 | 25 | |
| 16 | 26 | |
| 17 | 35 | |
| 18 | 89 | |
| 19 | 54 | |
| 20 | 5 |
About Ta‐Chung Chao
Ta‐Chung Chao is a scholar working on Oncology, Cancer Research and Genetics, having authored 99 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (16 papers), HER2/EGFR in Cancer Research (15 papers) and Advanced Breast Cancer Therapies (10 papers). The work is most often cited by research in Oncology (724 citations), Cancer Research (248 citations) and Pulmonary and Respiratory Medicine (485 citations). Ta‐Chung Chao has collaborated with scholars based in Taiwan, United States and Singapore. Frequent co-authors include Ling‐Ming Tseng, Liu H, Chueh‐Chuan Yen, Chun‐Yu Liu, Po‐Min Chen, Tzeon-Jye Chiou, Wei-Shu Wang, Chueh‐Chuan Yen, Muh‐Hwa Yang and Shyr‐Chyr Chen. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.